Elixir Capital Intrinsic Value
Elixir Capital intrinsic value. Elixir Capital (ELIXIR) median intrinsic value is ₹46.42 from 3 valuation models (range ₹31–₹111), vs current price ₹97.60 — -52.4% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Elixir Capital share price chart.
ELIXIR Valuation Methods Summary — DCF, Graham Number & P/E
Elixir Capital intrinsic value across 3 models vs current price ₹97.60 — upside/downside and value range per method. Read ELIXIR dividend history for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹110.67 | ₹99.60 - ₹121.74 | +13.4% | Book Value/Share: ₹138.33, P/B: 0.8x |
| Simple DCF (5Y) | dcf | ₹46.42 | ₹37.14 - ₹55.70 | -52.4% | CF Growth: 5.0%, Discount: 15% |
| Dividend Yield Method | dividend | ₹31.25 | ₹28.12 - ₹34.38 | -68.0% | DPS: ₹1.25, Target Yield: 4.0% |
ELIXIR Intrinsic Value vs Market Price — All Valuation Models
Elixir Capital fair value range ₹31–₹111 vs current market price ₹97.60 across 3 valuation models. Compare with ELIXIR fundamental valuation to assess whether the stock is under or overvalued.
ELIXIR Intrinsic Value Analysis — Undervalued or Overvalued?
Elixir Capital median intrinsic value ₹46.42, current price ₹97.60 — Trading Above Calculated Value by 52.4%, margin of safety -100.0%.
What is the intrinsic value of ELIXIR?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Elixir Capital (ELIXIR) is ₹46.42 (median value). With the current market price of ₹97.60, this represents a -52.4% variance from our estimated fair value.
The valuation range spans from ₹31.25 to ₹110.67, indicating ₹31.25 - ₹110.67.
Is ELIXIR undervalued or overvalued?
Based on our multi-method analysis, Elixir Capital (ELIXIR) appears to be trading above calculated value by approximately 52.4%.
ELIXIR Financial Health — Key Ratios vs Industry Benchmarks
Elixir Capital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 95.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -33.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 850.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | -0.03x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ELIXIR Cash Flow Quality — Operating & Free Cash Flow
Elixir Capital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹2 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-17 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |